Clinical Trials Browser

Phase 1 × ixazomib × Tumor-Agnostic × Clear all

NCT02942095 2023-04-18

Study of Ixazomib and Erlotinib in Solid Tumors

Phase 1 Completed

Neoplasm Metastasis